HD-OPM Archive
Topics › Plaque, CAC & CT angiography

Bacterial biofilms in coronary plaques may trigger heart attacks, Tampere study suggests

Louis Nervegna · Sep 13, 2025 · ♥ 4 reactions · 0 comments · original Facebook post
Plaque, CAC & CT angiographyInfections & vaccinesHeart attack, stroke & procedures
AI summary & key facts

Researchers at Tampere University found bacterial biofilms in cholesterol-rich coronary plaques that may lie dormant for decades and be activated by viral illness, driving inflammation and plaque rupture. Oral-microbe DNA was found in plaques, raising the prospect of vaccines or therapies, if validated.

#bacteriacvdHD #biofilmsHD #antiobioticsHD #vaccinesHD #plaqueHD #heartattackHD

Research cited

Scientists found bacteria in artery plaques that can trigger heart attacks — and vaccines could prevent it.

A surprising new study suggests that heart attacks may, in part, be infectious events triggered by hidden bacteria in the arteries. Researchers at Tampere University discovered that cholesterol-rich plaques in coronary arteries can harbor bacterial biofilms—dense, jelly-like structures that shield bacteria from both the immune system and antibiotics. These biofilms can lie dormant for decades, undetected and symptom-free, until a viral illness or other trigger activates them. Once awakened, the bacteria multiply, fueling inflammation that weakens plaque walls. This process can rupture the plaque, block blood flow, and ultimately cause a heart attack.

The findings provide direct evidence that bacterial DNA from oral microbes exists within atherosclerotic plaques, reinforcing long-standing suspicions about infection’s role in heart disease. Scientists even developed antibodies that revealed biofilm structures in arterial tissue and detected bacteria released during heart attacks. These results suggest that preventing myocardial infarction could one day involve vaccines or therapies designed to target biofilm-associated bacteria. If validated in further research, this approach could transform how doctors diagnose, treat, and even prevent the world’s leading cause of death.

Source: Karhunen, P. J., Pessi, T., Hörkkö, S., Karhunen, V., Goebeler, S., Louhelainen, A-M., Martiskainen, M., Haapaniemi, T., Lappeteläinen, J., Ijäs, T., Lyytikäinen, L-P., Raitoharju, E., Sioris, T., Tuomisto, S., Huhtala, H., Wang, C., Monaco, C., Oksala, N., Lehtimäki, T., & Laaksonen, R. (2025). Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic Plaques. Journal of the American Heart Association.

No photo description available.
← newer: PCSK9 inhibitors lower Lp(a) by an average of 27%, per meta-older: JAPAN-ACS sub-study: statins lowered AGEs, which were linked →